The global market for Atrial Septal Occluder is estimated to increase from US$ million in 2024 to reach US$ million by 2031, exhibiting a CAGR of % during 2025-2031. Keeping in mind the uncertainties of Trade War and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of trade war on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Atrial Septal Occluder market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The United States Atrial Septal Occluder market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The Europe Atrial Septal Occluder market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
The China Atrial Septal Occluder market is expected at value of US$ million in 2024 and grow at approximately % CAGR during 2024 and 2031.
Global key Atrial Septal Occluder players cover Abbott Laboratories, Medtronic Plc, Endologix Inc, LivaNova Plc and CryoLife Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2024.
[Report Coverage]
This latest report provides a deep insight into the global Atrial Septal Occluder market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Atrial Septal Occluder market, with both quantitative and qualitative data, to help readers understand how the Atrial Septal Occluder market scenario changed across the globe during trade war and Russia-Ukraine War.
The base year considered for analyses is 2024, while the market estimates and forecasts are given from 2025 to 2031. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
[Market Segmentation]
The study segments the Atrial Septal Occluder market and forecasts the market size by Type (Atrial Septal Defect Device and Ventricular Septal Defect Device,), by Application (Hospital, Outpatient Surgery Center and Specialty Clinics,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Atrial Septal Defect Device
Ventricular Septal Defect Device
Segmentation by application
Hospital
Outpatient Surgery Center
Specialty Clinics
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Laboratories
Medtronic Plc
Endologix Inc
LivaNova Plc
CryoLife Inc
Cook Group Incorporated
Edwards Lifesciences Corporation
W. L. Gore & Associates
Lepu Medical Technology
CeraFlex
[Chapter Introduction]
Chapter 1: Scope of Atrial Septal Occluder, Research Methodology, etc.
Chapter 2: Executive Summary, global Atrial Septal Occluder market size (sales and revenue) and CAGR, Atrial Septal Occluder market size by region, by type, by application, historical data from 2020 to 2025, and forecast to 2031.
Chapter 3: Atrial Septal Occluder sales, revenue, average price, global market share, and industry ranking by company, 2020-2024
Chapter 4: Global Atrial Septal Occluder sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Atrial Septal Occluder market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, Medtronic Plc, Endologix Inc, LivaNova Plc, CryoLife Inc, Cook Group Incorporated, Edwards Lifesciences Corporation, W. L. Gore & Associates and Lepu Medical Technology, etc.
Chapter 14: Research Findings and Conclusion
Table 1. Atrial Septal Occluder Annual Sales CAGR by Geographic Region (2020, 2025 & 2031) & ($ millions)
Table 2. Atrial Septal Occluder Annual Sales CAGR by Country/Region (2020, 2025 & 2031) & ($ millions)
Table 3. Major Players of Atrial Septal Defect Device
Table 4. Major Players of Ventricular Septal Defect Device
Table 5. Global Atrial Septal Occluder Sales by Type (2020-2024) & (K Units)
Table 6. Global Atrial Septal Occluder Sales Market Share by Type (2020-2024)
Table 7. Global Atrial Septal Occluder Revenue by Type (2020-2024) & ($ million)
Table 8. Global Atrial Septal Occluder Revenue Market Share by Type (2020-2024)
Table 9. Global Atrial Septal Occluder Sale Price by Type (2020-2024) & (US$/Unit)
Table 10. Global Atrial Septal Occluder Sales by Application (2020-2024) & (K Units)
Table 11. Global Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Table 12. Global Atrial Septal Occluder Revenue by Application (2020-2024)
Table 13. Global Atrial Septal Occluder Revenue Market Share by Application (2020-2024)
Table 14. Global Atrial Septal Occluder Sale Price by Application (2020-2024) & (US$/Unit)
Table 15. Global Atrial Septal Occluder Sales by Company (2022-2024) & (K Units)
Table 16. Global Atrial Septal Occluder Sales Market Share by Company (2022-2024)
Table 17. Global Atrial Septal Occluder Revenue by Company (2022-2024) ($ Millions)
Table 18. Global Atrial Septal Occluder Revenue Market Share by Company (2022-2024)
Table 19. Global Atrial Septal Occluder Sale Price by Company (2022-2024) & (US$/Unit)
Table 20. Key Manufacturers Atrial Septal Occluder Producing Area Distribution and Sales Area
Table 21. Players Atrial Septal Occluder Products Offered
Table 22. Atrial Septal Occluder Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Atrial Septal Occluder Sales by Geographic Region (2020-2024) & (K Units)
Table 26. Global Atrial Septal Occluder Sales Market Share Geographic Region (2020-2024)
Table 27. Global Atrial Septal Occluder Revenue by Geographic Region (2020-2024) & ($ millions)
Table 28. Global Atrial Septal Occluder Revenue Market Share by Geographic Region (2020-2024)
Table 29. Global Atrial Septal Occluder Sales by Country/Region (2020-2024) & (K Units)
Table 30. Global Atrial Septal Occluder Sales Market Share by Country/Region (2020-2024)
Table 31. Global Atrial Septal Occluder Revenue by Country/Region (2020-2024) & ($ millions)
Table 32. Global Atrial Septal Occluder Revenue Market Share by Country/Region (2020-2024)
Table 33. Americas Atrial Septal Occluder Sales by Country (2020-2024) & (K Units)
Table 34. Americas Atrial Septal Occluder Sales Market Share by Country (2020-2024)
Table 35. Americas Atrial Septal Occluder Revenue by Country (2020-2024) & ($ Millions)
Table 36. Americas Atrial Septal Occluder Revenue Market Share by Country (2020-2024)
Table 37. Americas Atrial Septal Occluder Sales by Type (2020-2024) & (K Units)
Table 38. Americas Atrial Septal Occluder Sales Market Share by Type (2020-2024)
Table 39. Americas Atrial Septal Occluder Sales by Application (2020-2024) & (K Units)
Table 40. Americas Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Table 41. APAC Atrial Septal Occluder Sales by Region (2020-2024) & (K Units)
Table 42. APAC Atrial Septal Occluder Sales Market Share by Region (2020-2024)
Table 43. APAC Atrial Septal Occluder Revenue by Region (2020-2024) & ($ Millions)
Table 44. APAC Atrial Septal Occluder Revenue Market Share by Region (2020-2024)
Table 45. APAC Atrial Septal Occluder Sales by Type (2020-2024) & (K Units)
Table 46. APAC Atrial Septal Occluder Sales Market Share by Type (2020-2024)
Table 47. APAC Atrial Septal Occluder Sales by Application (2020-2024) & (K Units)
Table 48. APAC Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Table 49. Europe Atrial Septal Occluder Sales by Country (2020-2024) & (K Units)
Table 50. Europe Atrial Septal Occluder Sales Market Share by Country (2020-2024)
Table 51. Europe Atrial Septal Occluder Revenue by Country (2020-2024) & ($ Millions)
Table 52. Europe Atrial Septal Occluder Revenue Market Share by Country (2020-2024)
Table 53. Europe Atrial Septal Occluder Sales by Type (2020-2024) & (K Units)
Table 54. Europe Atrial Septal Occluder Sales Market Share by Type (2020-2024)
Table 55. Europe Atrial Septal Occluder Sales by Application (2020-2024) & (K Units)
Table 56. Europe Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Table 57. Middle East & Africa Atrial Septal Occluder Sales by Country (2020-2024) & (K Units)
Table 58. Middle East & Africa Atrial Septal Occluder Sales Market Share by Country (2020-2024)
Table 59. Middle East & Africa Atrial Septal Occluder Revenue by Country (2020-2024) & ($ Millions)
Table 60. Middle East & Africa Atrial Septal Occluder Revenue Market Share by Country (2020-2024)
Table 61. Middle East & Africa Atrial Septal Occluder Sales by Type (2020-2024) & (K Units)
Table 62. Middle East & Africa Atrial Septal Occluder Sales Market Share by Type (2020-2024)
Table 63. Middle East & Africa Atrial Septal Occluder Sales by Application (2020-2024) & (K Units)
Table 64. Middle East & Africa Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Table 65. Key Market Drivers & Growth Opportunities of Atrial Septal Occluder
Table 66. Key Market Challenges & Risks of Atrial Septal Occluder
Table 67. Key Industry Trends of Atrial Septal Occluder
Table 68. Atrial Septal Occluder Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Atrial Septal Occluder Distributors List
Table 71. Atrial Septal Occluder Customer List
Table 72. Global Atrial Septal Occluder Sales Forecast by Region (2025-2031) & (K Units)
Table 73. Global Atrial Septal Occluder Sales Market Forecast by Region
Table 74. Global Atrial Septal Occluder Revenue Forecast by Region (2025-2031) & ($ millions)
Table 75. Global Atrial Septal Occluder Revenue Market Share Forecast by Region (2025-2031)
Table 76. Americas Atrial Septal Occluder Sales Forecast by Country (2025-2031) & (K Units)
Table 77. Americas Atrial Septal Occluder Revenue Forecast by Country (2025-2031) & ($ millions)
Table 78. APAC Atrial Septal Occluder Sales Forecast by Region (2025-2031) & (K Units)
Table 79. APAC Atrial Septal Occluder Revenue Forecast by Region (2025-2031) & ($ millions)
Table 80. Europe Atrial Septal Occluder Sales Forecast by Country (2025-2031) & (K Units)
Table 81. Europe Atrial Septal Occluder Revenue Forecast by Country (2025-2031) & ($ millions)
Table 82. Middle East & Africa Atrial Septal Occluder Sales Forecast by Country (2025-2031) & (K Units)
Table 83. Middle East & Africa Atrial Septal Occluder Revenue Forecast by Country (2025-2031) & ($ millions)
Table 84. Global Atrial Septal Occluder Sales Forecast by Type (2025-2031) & (K Units)
Table 85. Global Atrial Septal Occluder Sales Market Share Forecast by Type (2025-2031)
Table 86. Global Atrial Septal Occluder Revenue Forecast by Type (2025-2031) & ($ Millions)
Table 87. Global Atrial Septal Occluder Revenue Market Share Forecast by Type (2025-2031)
Table 88. Global Atrial Septal Occluder Sales Forecast by Application (2025-2031) & (K Units)
Table 89. Global Atrial Septal Occluder Sales Market Share Forecast by Application (2025-2031)
Table 90. Global Atrial Septal Occluder Revenue Forecast by Application (2025-2031) & ($ Millions)
Table 91. Global Atrial Septal Occluder Revenue Market Share Forecast by Application (2025-2031)
Table 92. Abbott Laboratories Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Atrial Septal Occluder Product Offered
Table 94. Abbott Laboratories Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. Medtronic Plc Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 98. Medtronic Plc Atrial Septal Occluder Product Offered
Table 99. Medtronic Plc Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 100. Medtronic Plc Main Business
Table 101. Medtronic Plc Latest Developments
Table 102. Endologix Inc Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 103. Endologix Inc Atrial Septal Occluder Product Offered
Table 104. Endologix Inc Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 105. Endologix Inc Main Business
Table 106. Endologix Inc Latest Developments
Table 107. LivaNova Plc Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 108. LivaNova Plc Atrial Septal Occluder Product Offered
Table 109. LivaNova Plc Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 110. LivaNova Plc Main Business
Table 111. LivaNova Plc Latest Developments
Table 112. CryoLife Inc Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 113. CryoLife Inc Atrial Septal Occluder Product Offered
Table 114. CryoLife Inc Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 115. CryoLife Inc Main Business
Table 116. CryoLife Inc Latest Developments
Table 117. Cook Group Incorporated Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 118. Cook Group Incorporated Atrial Septal Occluder Product Offered
Table 119. Cook Group Incorporated Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 120. Cook Group Incorporated Main Business
Table 121. Cook Group Incorporated Latest Developments
Table 122. Edwards Lifesciences Corporation Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 123. Edwards Lifesciences Corporation Atrial Septal Occluder Product Offered
Table 124. Edwards Lifesciences Corporation Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 125. Edwards Lifesciences Corporation Main Business
Table 126. Edwards Lifesciences Corporation Latest Developments
Table 127. W. L. Gore & Associates Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 128. W. L. Gore & Associates Atrial Septal Occluder Product Offered
Table 129. W. L. Gore & Associates Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 130. W. L. Gore & Associates Main Business
Table 131. W. L. Gore & Associates Latest Developments
Table 132. Lepu Medical Technology Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 133. Lepu Medical Technology Atrial Septal Occluder Product Offered
Table 134. Lepu Medical Technology Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 135. Lepu Medical Technology Main Business
Table 136. Lepu Medical Technology Latest Developments
Table 137. CeraFlex Basic Information, Atrial Septal Occluder Manufacturing Base, Sales Area and Its Competitors
Table 138. CeraFlex Atrial Septal Occluder Product Offered
Table 139. CeraFlex Atrial Septal Occluder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2022-2024)
Table 140. CeraFlex Main Business
Table 141. CeraFlex Latest Developments
List of Figures
Figure 1. Picture of Atrial Septal Occluder
Figure 2. Atrial Septal Occluder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atrial Septal Occluder Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Atrial Septal Occluder Revenue Growth Rate 2020-2031 ($ Millions)
Figure 8. Atrial Septal Occluder Sales by Region (2024 & 2031) & ($ millions)
Figure 9. Product Picture of Atrial Septal Defect Device
Figure 10. Product Picture of Ventricular Septal Defect Device
Figure 11. Global Atrial Septal Occluder Sales Market Share by Type in 2024
Figure 12. Global Atrial Septal Occluder Revenue Market Share by Type (2020-2024)
Figure 13. Atrial Septal Occluder Consumed in Hospital
Figure 14. Global Atrial Septal Occluder Market: Hospital (2020-2024) & (K Units)
Figure 15. Atrial Septal Occluder Consumed in Outpatient Surgery Center
Figure 16. Global Atrial Septal Occluder Market: Outpatient Surgery Center (2020-2024) & (K Units)
Figure 17. Atrial Septal Occluder Consumed in Specialty Clinics
Figure 18. Global Atrial Septal Occluder Market: Specialty Clinics (2020-2024) & (K Units)
Figure 19. Global Atrial Septal Occluder Sales Market Share by Application (2020-2024)
Figure 20. Global Atrial Septal Occluder Revenue Market Share by Application in 2024
Figure 21. Atrial Septal Occluder Revenue Market by Company in 2024 ($ Million)
Figure 22. Global Atrial Septal Occluder Revenue Market Share by Company in 2024
Figure 23. Global Atrial Septal Occluder Sales Market Share by Geographic Region (2020-2024)
Figure 24. Global Atrial Septal Occluder Revenue Market Share by Geographic Region in 2024
Figure 25. Global Atrial Septal Occluder Sales Market Share by Region (2020-2024)
Figure 26. Global Atrial Septal Occluder Revenue Market Share by Country/Region in 2024
Figure 27. Americas Atrial Septal Occluder Sales 2020-2024 (K Units)
Figure 28. Americas Atrial Septal Occluder Revenue 2020-2024 ($ Millions)
Figure 29. APAC Atrial Septal Occluder Sales 2020-2024 (K Units)
Figure 30. APAC Atrial Septal Occluder Revenue 2020-2024 ($ Millions)
Figure 31. Europe Atrial Septal Occluder Sales 2020-2024 (K Units)
Figure 32. Europe Atrial Septal Occluder Revenue 2020-2024 ($ Millions)
Figure 33. Middle East & Africa Atrial Septal Occluder Sales 2020-2024 (K Units)
Figure 34. Middle East & Africa Atrial Septal Occluder Revenue 2020-2024 ($ Millions)
Figure 35. Americas Atrial Septal Occluder Sales Market Share by Country in 2024
Figure 36. Americas Atrial Septal Occluder Revenue Market Share by Country in 2024
Figure 37. United States Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 38. Canada Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 39. Mexico Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 40. Brazil Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 41. APAC Atrial Septal Occluder Sales Market Share by Region in 2024
Figure 42. APAC Atrial Septal Occluder Revenue Market Share by Regions in 2024
Figure 43. China Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 44. Japan Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 45. South Korea Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 46. Southeast Asia Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 47. India Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 48. Australia Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 49. Europe Atrial Septal Occluder Sales Market Share by Country in 2024
Figure 50. Europe Atrial Septal Occluder Revenue Market Share by Country in 2024
Figure 51. Germany Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 52. France Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 53. UK Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 54. Italy Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 55. Russia Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 56. Middle East & Africa Atrial Septal Occluder Sales Market Share by Country in 2024
Figure 57. Middle East & Africa Atrial Septal Occluder Revenue Market Share by Country in 2024
Figure 58. Egypt Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 59. South Africa Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 60. Israel Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 61. Turkey Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 62. GCC Country Atrial Septal Occluder Revenue Growth 2020-2024 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Atrial Septal Occluder in 2024
Figure 64. Manufacturing Process Analysis of Atrial Septal Occluder
Figure 65. Industry Chain Structure of Atrial Septal Occluder
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
※参考情報 心房中隔オクルーダーは、心房中隔欠損症(ASD)に対する治療法として広く用いられるデバイスです。この装置は、心房中隔に存在する欠損部を閉じることで、心臓機能の改善を目指します。心房中隔欠損症とは、心房間の壁(心房中隔)に穴が開いている先天性の心疾患であり、その穴により左心房と右心房の間に異常な血流が生じます。これが長期的に続くと、心臓の負担が増加し、肺や全身に対する血流にも影響を及ぼす可能性があります。 心房中隔オクルーダーの特徴は、その設計と機能にあります。通常、このデバイスは二つのパーツから構成されており、一つが心房中隔の上部、もう一つが下部に固定されます。デバイスは非常に柔軟で、心房の形状に合わせて適応可能です。また、外科的な手法を用いることなく、カテーテルを通じて体内に挿入できるため、手術に比べて侵襲性が低いという大きな利点があります。この手法は、入院期間が短縮され、回復も早いことが特徴です。 心房中隔オクルーダーにはいくつかの種類があります。最も一般的なものは、アムプトス型およびドーム型オクルーダーです。アムプトス型は、特に大きな欠損に対応できるデザインであり、一方の側面がフラットな形状をしており、もう一方はドーム型になっています。これにより、さまざまなサイズの欠損にフィットすることが可能です。ドーム型は、主に小さな欠損に適しており、簡単な挿入が可能です。 用途としては、心房中隔欠損症の治療が最も広く知られています。このデバイスは、小児から成人まで、幅広い年齢層の患者に使用されることが可能です。従来は外科手術による治療が一般的でしたが、オクルーダーの使用により、治療の選択肢が多様化しました。カテーテル治療は、手術に伴うリスクを大幅に低減し、術後合併症の発生率を下げることができるため、患者にとって魅力的です。 関連技術として、内視鏡的な手法や超音波検査技術があげられます。これらの技術は、デバイスの挿入および効果の確認に非常に重要です。例えば、経食道心エコー検査は、オクルーダーの適切な位置や閉鎖状態を確認するために使用され、術中及び術後のガイダンスとして活用されます。また、MRIやCTスキャンも、デバイスの位置や機能をモニタリングする上で重要な役割を果たします。 全体として、心房中隔オクルーダーは、心房中隔欠損症の治療における革命的な進歩を象徴しています。患者に対する負担が軽減され、より迅速な回復が期待できるため、これからの心臓治療においてもその役割はますます重要になると考えられています。心房中隔オクルーダーの普及によって、多くの患者が心臓の問題から解放され、より健康的な生活を送ることができるようになることが期待されています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/